PSYQP - Overview: Psychotropic Pharmacogenomics Gene Panel, Varies
Individualizing selection and dosage of medications prescribed for treatment of depression and other psychiatric disorders based on genetic variation Identifying genetic variation in genes known to be associated with response and/or risk...
APOA1 - Overview: Apolipoprotein A1, Serum
Evaluating risk for atherosclerotic cardiovascular disease Aiding in the detection of Tangier disease
BRIVA - Overview: Brivaracetam, Plasma
Assessing compliance and toxicity for brivaracetam
ETGC - Overview: Ethyl Glucuronide Confirmation, Random, Urine
Monitoring abstinence in clinical and justice system settings
MTHX - Overview: Methotrexate, Serum
Determining whether methotrexate is being cleared appropriately and verifying that a nontoxic concentration has been attained following therapy
MPA - Overview: Mycophenolic Acid, Serum
Monitoring therapy to ensure adequate blood levels and avoid over-immunosuppression
MGS - Overview: Magnesium, Serum
Monitoring preeclampsia patients being treated with magnesium sulfate, although in most cases monitoring clinical signs (respiratory rate and deep tendon reflexes) is adequate and blood magnesium levels are not required
FRT4 - Overview: T4 (Thyroxine), Free, Serum
Evaluating suspected thyroid function disorders using free thyroxine measured together with thyroid-stimulating hormone
RETZZ - Overview: Multiple Endocrine Neoplasia Type 2 Syndrome, RET, Full Gene Analysis, Varies
Evaluating patients with a personal or family history suggestive of a multiple endocrine neoplasia type 2 (MEN2) or Hirschsprung disease (HSCR) Establishing a diagnosis of MEN2 or HSCR allowing for targeted cancer surveillance based on...
MSAES - Overview: Myositis Specific Antibody Evaluation, Serum
Accurately diagnosing, classifying, and managing idiopathic inflammatory myopathies (IIM) by identifying subtype-specific biomarkers that guide prognosis and treatment Enabling early detection of IIM, particularly in atypical or severe...
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.